Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Genomma Lab: revenue 2013-2018

Revenue generated by Genomma Lab from 2013 to 2018 (in billion Mexican pesos)

by Ana Maria Rios Montanez, last edited May 17, 2019
Genomma Lab: revenue 2013-2018 This statistic shows the revenue generated by Genomma Lab from 2013 to 2018. Genomma Lab is one of the leading pharmaceutical and personal care companies in Mexico, with a high international presence. In 2018, Genomma Lab generated around 11.79 billion Mexican pesos in revenue.
Show more

Revenue generated by Genomma Lab from 2013 to 2018 (in billion Mexican pesos)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Over-the-counter medicine industry in the United Kingdom"
  • Overview
The most important statistics
  • Pharmacy
  • Over-the-counter medication
  • Annual change in sales value
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.